Catalysis plays a pivotal role in the development and action of raltegravir. The enzyme HIV integrase is a biological catalyst that facilitates the integration of viral DNA into the host cell genome. Raltegravir acts by inhibiting this enzyme, thus interfering with the catalytic process essential for viral replication. Understanding the catalytic mechanism of the HIV integrase enzyme has been crucial in designing effective inhibitors like raltegravir.
